Moxifloxacin Impurity 23, with the CAS number 855661-74-4, is a chemical compound associated with the antibiotic moxifloxacin, which belongs to the fluoroquinolone class of antibiotics. This impurity is typically a byproduct formed during the synthesis of moxifloxacin and may arise from various reaction conditions or starting materials. While specific characteristics such as melting point, boiling point, and solubility may vary, impurities like this one are generally characterized by their structural similarity to the parent compound, potentially affecting the pharmacological properties and stability of the final product. The presence of impurities in pharmaceutical compounds is critical to assess, as they can influence efficacy, safety, and regulatory compliance. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities in pharmaceutical formulations. Understanding the characteristics and behavior of Moxifloxacin Impurity 23 is essential for ensuring the quality and safety of moxifloxacin-containing medications.

Moxifloxacin Impurity 23

855661-74-4: Moxifloxacin Impurity 23, with the CAS number 855661-74-4, is a chemical compound associated with the antibiotic moxifloxacin, which belongs to the fluoroquinolone class of antibiotics. This impurity is typically a byproduct formed during the synthesis of moxifloxacin and may arise from various reaction conditions or starting materials. While specific characteristics such as melting point, boiling point, and solubility may vary, impurities like this one are generally characterized by their structural similarity to the parent compound, potentially affecting the pharmacological properties and stability of the final product. The presence of impurities in pharmaceutical compounds is critical to assess, as they can influence efficacy, safety, and regulatory compliance. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities in pharmaceutical formulations. Understanding the characteristics and behavior of Moxifloxacin Impurity 23 is essential for ensuring the quality and safety of moxifloxacin-containing medications.

CAS 855661-74-4

Moxifloxacin Impurity 23

Moxifloxacin Impurity 23

Ref: 4Z-M-2747

(1R,6S)-trans-Moxifloxacin

Ref: TR-M745025